Work

Identification of an argpyrimidine-modified protein in human red blood cells from schizophrenic patients: A possible biomarker for diseases involving carbonyl stress

Year: 2017

Type: article

Study design: Observational Study

Source: Biochemical and Biophysical Research Communications

DOI: 10.1016/j.bbrc.2017.08.150

Authors: Y.I. Ishida, T. Kayama, Y. Kibune, S. Nishimoto, S. Koike, T. Suzuki, Y. Horiuchi, M. Miyashita, M. Itokawa, M. Arai, Y. Ogasawara

Institutions: Meiji Pharmaceutical University, Tokyo Metropolitan Institute of Medical Science

Language: English

Topic: Advanced Glycation End Products research

Subfield: Clinical Biochemistry

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Japan Society for the Promotion of Science

Awards: Study of biomarker as a mediator for appropriate diagnosis and medication for schizophrenia, Inhibition of carbonyl stress via Nrf2 activation and its application for the treatment-resistant schizophrenia

OpenAlex ID: W2750763701

FWCI: 1.822

Cites: 27

Cited by: 20

Related to: 10